SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : RMGG

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Chris K. who wrote (1078)11/29/1999 11:03:00 AM
From: Chris K.  Read Replies (1) of 1170
 
(COMTEX) B: Rocky Mountain -- Fuzhou -- Drug Co. Ltd. Signs Purchase
B: Rocky Mountain -- Fuzhou -- Drug Co. Ltd. Signs Purchase Order Agreement
With 500 Store Chinese Drug Chain

FUZHOU, China, Nov 29, 1999 (BUSINESS WIRE) --



Agreement with Quanhou Da Tong Medicine Co. Ltd.
is expected to exceed $500,00 per year in revenue

Mr. Brian Hodge, Managing Director of Rocky Mountain (Fuzhou) Drug
Co. Ltd. (OTCBB:RMGG)("RMGG China") announced today that it has
received purchase orders from Quanzhou Da Tong Medicine Co. Ltd.
("Quanzhou Medicine Co.") to immediately supply both processed and
unprocessed ginseng root to its 500 plus stores in the Quanzhou region
of Fujian, China.

RMGG China will also provide collateral support and participate in
additional promotional activities to support marketing and sales
initiatives for the retail chain.

"The first major contract for RMGG China is now in place. We project in
excess of $500,000 US revenue per annum from this initial contract,"
stated Mr. Brian Hodge. "We look forward to expanding our customer base
into additional Chinese cities and provinces. With a population of over
1.3 billion people the Chinese market presents limitless opportunity,"
concluded Mr. Hodge.

"Now that the door to China is open via the recent trade agreement
between China and the USA we can rapidly look to expand our product
base and fully exploit the massive market in the Peoples Republic of
China. This initial agreement with Quanzhou Medicine Co. will put RMGG
on the map in China and provide the spring board for our explosive
growth plans," stated Mr. Robert Bell, President of Rocky Mountain
Ginseng, Inc. ("RMGG").

Mr. Su Shao Pen, President of Quanzhou Da Tong Medicine Co. Ltd.
commented at the signing ceremony that he sees a great future for RMGG
and Quanzhou Medicine Co.'s relationship. He also indicated he looks
forward to an expanded product offering from RMGG China as RMGG sources
additional pharmaceutical and healthy products from the American
market.

About Quanzhou Da Tong Medicine Co. Ltd. -- Quanzhou Medicine Co. is
one of the largest drug store chains in the Fujian province.
Headquartered in Quanzhou City with a population of over 6 million
people, the company operates over 500 retail drug outlets.

About Rocky Mountain Ginseng, Inc. -- Rocky Mountain Ginseng, Inc.'s
head office is located in British Columbia, Canada. The Company exports
Canadian grown American ginseng as well as processed American ginseng
products to China. Rocky Mountain Ginseng, Inc. holds exclusive world
processing and distribution rights to several innovative value added
ginseng products developed in North America.

Rocky Mountain Ginseng, Inc. ("RMGG") purchased Fuzhou Fujian Drug
Company located in China in February, 1999. This acquisition included
all necessary drug and hygiene licences allowing the Company to import,
export manufacture and distribute ginseng products in all provinces in
China. RMGG's ownership of these drug and hygiene permits is
additionally important as it allows RMGG to import pharmaceutical and
healthy food products from the USA and other Western countries. The
Company will actively pursue this business opportunity. The Company has
completed the construction of its new office and manufacturing facility
in the city of Fuzhou and is currently producing traditional ginseng
products from the Chinese market. The Chinese factory employs 27 people
in processing, sales, accounting and management. Rocky Mountain
(Fuzhou) Drug Co. Ltd. is a 100% wholly owned American company in the
Fujian province.

This press release contains certain forward-looking statements make
pursuant to the safe harbor provisions of the Private Securities
Litigation Act of 1995. Expression of future goals and similar
expressions reflecting something other than historical fact involve
risks and uncertainties. The actual results the Company achieves may
differ materially from any forward-looking statements due to such risks
and uncertainties.



Copyright (C) 1999 Business Wire. All rights reserved.



Distributed via COMTEX.
-0-
CONTACT: Rocky Mountain Ginseng, Inc.
Robert L. Bell, 604/420-0095
rlbell@direct.ca (e-mail)
www.direct.ca/ginseng
or
JGS Management Group
Jerry Simek, 858/453-0772
jgsgroup@aol.com (e-mail)
or
Rocky Mountain (Fuzhou) Drug Co. Ltd.
Brian A. Hodge/Mr. Su Shao Pen, (86) 591-379-7969
rockymt@public.fz.fj.cn (e-mail)
or
PMR & Associates, LLC
Patrick Rost, 760/942-0772
pmrandco@aol.com (e-mail)

WEB PAGE: businesswire.com

GEOGRAPHY: INTERNATIONAL ASIA PACIFIC CANADA

INDUSTRY CODE: PHARMACEUTICAL
MEDICINE
ALTERNATIVE
MEDICINE

Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.

*** end of story ***
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext